Results 121 to 130 of about 80,863 (210)

Avascular necrosis as an uncommon manifestation in glycogen storage disease type III: diagnostic and therapeutic challenges. [PDF]

Oxf Med Case Reports
Gorial FI, Awadh NI, Khunda SS, Al-Badri SG, Alibrahimi AF.   +4 more
europepmc   +1 more source

Hypercholesterolemia Successfully Treated With Two Different PCSK9 Inhibitors in a Patient With Glycogen Storage Disease IXd: Phosphorylase Kinase Deficiency. [PDF]

J Lipid Atheroscler
Huynh T, Nguyen H, Nguyen M.
europepmc   +1 more source

Empagliflozin as treatment in glycogen storage disease type IB patients. [PDF]

Mol Genet Metab Rep
Arbelo Rodríguez M, Márquez Mesa E, Lorenzo González C, Gutiérrez Vilar M, Arhip L, Ruiz Pons M, Suárez Llanos JP.   +6 more
europepmc   +1 more source

Portasystemic shunting for metabolic disease [PDF]

, 1979
Benichou, J, Starzl, TE
core  

Efficacy of magnetic resonance imaging in managing glycogen storage disease. [PDF]

Orphanet J Rare Dis
Ahn JH, Jeong YW, Choi YB, Kang Y.
europepmc   +1 more source

Growth impairment in glycogen storage disease type I versus types III/VI/IX: a cross-sectional study. [PDF]

BMC Pediatr
Wu X, Sun Y, Yang M.
europepmc   +1 more source

Pediatric Hepatology: A three-year experience with pediatric liver transplantation with cyclosporine and steroids [PDF]

, 1986
Gartner, JC, Iwatsuki, S, Malatack, JJ, Shaw, BW, Starzl, TE, Urbach, AH, Zitelli, BH   +6 more
core  

Surgery for metabolic liver disease [PDF]

, 1986
Starzl, TE
core  

Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia. [PDF]

JIMD Rep
Laufs V, Hasenburg A, Busch MA, Lang F, Macchiella D, Mildenberger E, Seidmann L, Hennermann JB.   +7 more
europepmc   +1 more source